Prevalence of hypercalcaemia in patients on maintenance lithium therapy monitored in primary care

Irish Medical Journal

Volumn 106, Issue 1, 2013, Pages 1-2

  Lally, J ^a   Lee, B ^b   McDonald, C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LITHIUM SALT; PARATHYROID HORMONE;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CALCIUM BLOOD LEVEL; DEPRESSION; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREVALENCE; PRIMARY MEDICAL CARE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 84875009315     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cade JF. Lithium salts in the treatment of psychotic excitement. The Medical journal of Australia. 1949;2:349-352.
2. Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den Brink W. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. Bipolar Disorders. 2007;9:793-798.
3. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161:217-222.
4. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001;3.
5. Cipriani A, Smith K, Burgess S, Carney S, Goodwin G, Geddes J. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev. 2006;18.
6. Wilting I, Souverein PC, Nolen WA, Egberts AC, Heerdink ER. Changes in outpatient lithium treatment in the Netherlands during 1996-2005. J Affect Disord. 2008;111:94-99.
7. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol. 2006;20:347-355.
8. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry. 1999;175:336-339.
9. Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol. 1994;40:759-764.
10. Peselow ED, Dunner DL, Fieve RR, Lautin A. Lithium carbonate and weight gain. J Affect Disord. 1980;2:303-310.
11. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10:329-345.
12. Bassilios N, Martel P, Godard V, Froissart M, Grnfeld J-P, Stengel B. Monitoring of glomerular filtration rate in lithium-treated outpatients an ambulatory laboratory database surveillance. Nephrology Dialysis Transplantation. 2008;23:562-565.
13. NICE clinical guideline 38. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. July 2006.
14. Department of Health. Annex A: Quality indicators Summary of points. Qualities and Outcomes Framework. updated 2004. p. 60.
15. Practice guideline for the treatment of patients with bipolar disorder (revision): Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50.
16. Garfinkel PE, Ezrin C, Stancer HC. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet. 1973;2:331-332.
17. Saunders BD, Saunders EF, Gauger PG. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg. 2009;33:2314-2323.
18. Khandwala HM, Van Uum S. Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract. 2006;12:54-58.
19. Melton LJ, 3rd. Epidemiology of primary hyperparathyroidism. J Bone Miner Res. 1991;6:S31-S32.
20. Riccardi D, Gamba G. The many roles of the calcium-sensing receptor in health and disease. Arch Med Res. 1999;30:436-448.
21. Shen F-H, Sherrard DJ. Lithium-Induced Hyperparathyroidism: An Alteration of the Set-Point. Annals of Internal Medicine. 1982;96:63-65.
22. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2003;42:S1-S201.
23. Bendz H, Sjdin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy a cross-sectional study and the effect of lithium withdrawal. Journal of Internal Medicine. 1996;240:357-365.
24. Jones BJ, Twomey PJ. Requesting patterns for serum calcium concentration in patients on long-term lithium therapy. Int J Clin Pract. 2009;63:170-172.
25. Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg. 2003;27:486-488.
26. Sloand JA, Shelly MA. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis. 2006;48:832-837.